Advertisement

CDC Responds To Concerns About Superbug Tracking

07:14
Download Audio
Resume
Beth Bell, director of the National Center for Emerging and Zoonotic Infectious Diseases of Centers for Disease Control and Prevention, testifies during a hearing before the Africa, Global Health, Global Human Rights and International Organizations Subcommittee of the House Foreign Affairs Committee on "Global Efforts to Fight Ebola" on Sept. 16, 2014 in Washington. (Alex Wong/Getty Images)
Beth Bell, director of the National Center for Emerging and Zoonotic Infectious Diseases of Centers for Disease Control and Prevention, testifies during a hearing before the Africa, Global Health, Global Human Rights and International Organizations Subcommittee of the House Foreign Affairs Committee on "Global Efforts to Fight Ebola" on Sept. 16, 2014 in Washington. (Alex Wong/Getty Images)

Reuters reporters spoke with Here & Now in September about their investigation into how the U.S. tracks deaths related to drug-resistant infections — or superbugs. They found a shocking lack of data, largely because of inconsistent tracking practices across different hospitals and states.

Responding to the claims, Dr. Beth Bell, director of the Center for Disease Control's National Center for Emerging and Zoonotic Infectious Diseases, speaks with Here & Now's Robin Young about solutions for tracking and fighting superbugs.

Guest

Dr. Beth Bell, director of the Center for Disease Control’s National Center for Emerging and Zoonotic Infectious Diseases. The center tweets @CDC_NCEZID.

This segment aired on October 5, 2016.

Related:

Advertisement

More from Here & Now

Listen Live
Close